{"id":"tp-50877","type":"article-newspaper","title":"vTv Therapeutics Posts a $0.94 Q3 GAAP Loss Per Share, 15 Cents Better Than Estimate","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/50877","datePublished":"2026-11-07T14:32:53.000Z","dateModified":"2026-11-07T14:32:53.000Z","language":"en","abstract":"Cash and cash equivalents were $77.2 million on Sept. 30, 2026, compared with $88.9 million on Dec. 31, 2025.","section":"Business","references":[]}